As much of the world moves on from the early chaos of the pandemic, a new COVID-19 variant is quietly making its way through ...

Health officials are tracking a highly contagious new COVID-19 variant. This comes as confusion grows over vaccine ...

Health officials are tracking a new COVID-19 variant. This comes as confusion grows over vaccine recommendations moving ...

A major revision to the schedule for COVID-19 vaccines comes on the heels of Sen. Ron Johnson’s, R-Wis., issuance of an ...

Objective To determine distinct patterns of patients with autoimmune diseases harbouring anti-Ku antibodies and their respective prognosis.Methods Anti-Ku-positive patients were retrieved through four ...

Moderna, over the weekend, announced that the U.S. Food and Drug Administration had approved its second-generation COVID ...

The national emergency response in the U.S. to COVID-19 ended in April 2023. Previous COVID vaccines have also caused such side effects as myocarditis and pericarditis, conditions involving ...

Alkermes plc (Nasdaq: ALKS) today announced the presentation of accepted research at key scientific conferences this spring, ...

Myocarditis and pericarditis following mRNA COVID-19 vaccines have occurred most commonly in males 12 years through 24 years of age. You should seek medical attention right away if you or your child ...

For those who experienced symptoms like heart inflammation ... to the Pfizer and Moderna labels about the risk of myocarditis and pericarditis. But by then, millions of people — including ...

NEXSPIKE becomes Moderna's third FDA-approved product CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has ...

CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved mNEXSPIKE® (mRNA-1283), a new vaccine ...